Obesity and co-morbidities in type 2 diabetes: an opportunity to bend the Health Care Cost Curve

Published: February 14, 2014
Category: Papers
Authors: Kristensen T, Yderstraede K
Country: Denmark
Language: null
Type: Population Health
Settings: Health Plan, PCP

Rev Clin Esp 214:140-142.

University of Southern Denmark, Odense, Denmark

Obesity has long been known as a driver and predictor of the increasing global prevalence of type 2 diabetes mellitus. The World Health Organisation (WHO) has projected that more than 532 million people will developed diabetes by 2030. In Spain the evidence on the incidence of type 2 diabetes is limited due to insufficient data.1 However, it is recognized that both the incidence and the prevalence of type 2 diabetes are increasing and the age at diagnosis is decreasing. A recent national survey found that the prevalence of type 2 diabetes in Spain is 13.8% (95% CI 12.8–14.7%).2 This prevalence can be subdivided into patients who have been diagnosed (7.8%) and those not yet diagnosed (6%). A lower prevalence of 10.3% has been reported in Catalonia and the prevalence of undiagnosed type 2 diabetes was 6.7% in this area. The national survey supported the association between diabetes and obesity. Spain’s obesity prevalence rate of 28.2% ranks among the highest in the OECD countries.

Denmark,Co-morbidy,High Risk,High-Impact Chronic Conditions,Diabetes Mellitus,Type 2/complications,Type 2/economics,Global Health,Obesity/complications,Obesity/economics,Prevalence

Please log in/register to access.

Log in/Register

LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top